Search
for
Sort by
Research 691–720 of 1000+
- Five‐year experience in the treatment of alopecia areata with DPC
- Intralesional steroids for alopecia areata
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)
- Cephalalgic Alopecia Areata
- Systematic review of platelet‐rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability
- Treatments for alopecia areata: A systematic review and network meta‐analysis
- Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- High-dose steroid pulse therapy for the treatment of severe alopecia areata.
- Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample
- Comparative evaluation of Intralesional Triamcinolone Acetonide Injection, narrow band Ultraviolet B, and their combination in Alopecia Areata
- Development of Autoimmune Hair Loss Disease Alopecia Areata Is Associated with Cardiac Dysfunction in C3H/HeJ Mice
- Excimer Laser: A Module of the Alopecia Areata Common Protocol
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Triamcinolone Suspension in Alopecia Areata
- Intravenous methylprednisolone pulse therapy in severe alopecia areata
- Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata
- Alopecia areata – Current understanding and management
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Histopathological investigation of clinically non‐affected perilesional scalp in alopecias detected unexpected spread of disease activities
- Evaluation of utility of phenol in alopecia areata
- Histopathologic profile of alopecia areata in Indian patients
- Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study